Magnetic field tech captures the ‘song’ of a drug

EMulate Therapeutics uses magnetic field technology to emulate drug effects in humans and animal models without using chemicals.

Magnetic fields are all around us. They exist whenever there is electric current and have been used in various aspects of medicine for decades. Today, magnetic fields are used in applications including magnetic resonance imaging (MRI), bone fracture repair, wound healing and pain reduction.

Taking things a step further, US startup?EMulate Therapeutics?has developed a unique magnetic field technology that has been shown to replicate the effect of drugs in humans and animal models – all without the presence of chemicals. Having spun-out companies in cancer, pain management and beyond, the company is seeking partners for longevity applications of its technology.

My take on this: The concept behind EMulate’s approach is mind-boggling. The company “records” the electromagnetic signature of specific molecules and is then able to use those recordings to effect changes in cellular behaviour, without using chemicals. In its most advanced programme, EMulate’s technology has completed?feasibility clinical trials?for adults and children with terminal brain cancer, using a recording derived from chemotherapy drug paclitaxel. We caught up with EMulate’s CEO Chris Rivera to find out more.

EMulate has more than 40 patents on its proprietary technology, which uses ultra-low radio frequency energy to produce therapeutic biological effects. The technology builds on ultra-sensitive listening devices developed by the US government during the Cold War period.

“These superconducting quantum interference devices (SQUIDs) are extremely sensitive listening devices called magnetometers,” says Rivera. “But instead of using a magnetometer to listen to a conversation in Beijing or Moscow, or a submarine in the middle of the Pacific Ocean, we use it to listen to molecules.”

Read the full article HERE.

Thanks for reading! If you’ve enjoyed this article, it would mean a lot to me if you could subscribe and share it on LinkedIn!